Flister MJ - Search Results

1

New model of macrophage acquisition of the lymphatic endothelial phenotype.

Hall KL, Volk-Draper LD, Flister MJ, Ran S. Hall KL, et al. Among authors: flister mj. PLoS One. 2012;7(3):e31794. doi: 10.1371/journal.pone.0031794. Epub 2012 Mar 2. PLoS One. 2012. PMID: 22396739 Free PMC article.

2

Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.

Flister MJ, Wilber A, Hall KL, Iwata C, Miyazono K, Nisato RE, Pepper MS, Zawieja DC, Ran S. Flister MJ, et al. Blood. 2010 Jan 14;115(2):418-29. doi: 10.1182/blood-2008-12-196840. Epub 2009 Nov 9. Blood. 2010. PMID: 19901262 Free PMC article.

3

Characterization of Prox1 and VEGFR-3 expression and lymphatic phenotype in normal organs of mice lacking p50 subunit of NF-κB.

Flister MJ, Volk LD, Ran S. Flister MJ, et al. Microcirculation. 2011 Feb;18(2):85-101. doi: 10.1111/j.1549-8719.2010.00057.x. Microcirculation. 2011. PMID: 21166921 Free PMC article.

4

Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.

Whitehurst B, Flister MJ, Bagaitkar J, Volk L, Bivens CM, Pickett B, Castro-Rivera E, Brekken RA, Gerard RD, Ran S. Whitehurst B, et al. Among authors: flister mj. Int J Cancer. 2007 Nov 15;121(10):2181-91. doi: 10.1002/ijc.22937. Int J Cancer. 2007. PMID: 17597103 Free article.

5

Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-vascular endothelial growth factor A therapy.

Volk LD, Flister MJ, Bivens CM, Stutzman A, Desai N, Trieu V, Ran S. Volk LD, et al. Among authors: flister mj. Neoplasia. 2008 Jun;10(6):613-23. doi: 10.1593/neo.08302. Neoplasia. 2008. PMID: 18516298 Free PMC article.

6

Lymphangiogenesis and lymphatic metastasis in breast cancer.

Ran S, Volk L, Hall K, Flister MJ. Ran S, et al. Among authors: flister mj. Pathophysiology. 2010 Sep;17(4):229-51. doi: 10.1016/j.pathophys.2009.11.003. Epub 2009 Dec 24. Pathophysiology. 2010. PMID: 20036110 Free PMC article.

7

Molecular profile and proliferative responses of rat lymphatic endothelial cells in culture.

Whitehurst B, Eversgerd C, Flister M, Bivens CM, Pickett B, Zawieja DC, Ran S. Whitehurst B, et al. Lymphat Res Biol. 2006;4(3):119-42. doi: 10.1089/lrb.2006.4.119. Lymphat Res Biol. 2006. PMID: 17034293

8

Synergy of nab-paclitaxel and bevacizumab in eradicating large orthotopic breast tumors and preexisting metastases.

Volk LD, Flister MJ, Chihade D, Desai N, Trieu V, Ran S. Volk LD, et al. Among authors: flister mj. Neoplasia. 2011 Apr;13(4):327-38. doi: 10.1593/neo.101490. Neoplasia. 2011. PMID: 21472137 Free PMC article.

9

Host genetic modifiers of nonproductive angiogenesis inhibit breast cancer.

Flister MJ, Tsaih SW, Stoddard A, Plasterer C, Jagtap J, Parchur AK, Sharma G, Prisco AR, Lemke A, Murphy D, Al-Gizawiy M, Straza M, Ran S, Geurts AM, Dwinell MR, Greene AS, Bergom C, LaViolette PS, Joshi A. Flister MJ, et al. Breast Cancer Res Treat. 2017 Aug;165(1):53-64. doi: 10.1007/s10549-017-4311-8. Epub 2017 May 31. Breast Cancer Res Treat. 2017. PMID: 28567545 Free PMC article.

10

CXM: a new tool for mapping breast cancer risk in the tumor microenvironment.

Flister MJ, Endres BT, Rudemiller N, Sarkis AB, Santarriaga S, Roy I, Lemke A, Geurts AM, Moreno C, Ran S, Tsaih SW, De Pons J, Carlson DF, Tan W, Fahrenkrug SC, Lazarova Z, Lazar J, North PE, LaViolette PS, Dwinell MB, Shull JD, Jacob HJ. Flister MJ, et al. Cancer Res. 2014 Nov 15;74(22):6419-29. doi: 10.1158/0008-5472.CAN-13-3212. Epub 2014 Aug 29. Cancer Res. 2014. PMID: 25172839 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page